Loading: 100%
SHARPS COMPLIANCE CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 130 (as per FY 2016)no data available
Sector Waste Management, IndustrialsWaste Management, Industrialsno data available
Ticker SMEDno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 172,53,54,55,56,5
datesClosing price (adj.)
13.10.20174.44
11.10.20174.42
04.10.20174.80
27.09.20174.93
20.09.20175.01
13.09.20174.92
06.09.20174.75
30.08.20175.07
23.08.20175.19
16.08.20175.67
09.08.20174.94
02.08.20174.67
26.07.20174.42
19.07.20174.26
12.07.20174.33
05.07.20174.22
27.06.20174.11
20.06.20174.00
13.06.20174.08
06.06.20174.22
30.05.20174.19
23.05.20174.18
16.05.20174.17
09.05.20174.37
02.05.20174.33
25.04.20174.55
18.04.20174.42
11.04.20174.34
04.04.20174.58
28.03.20174.69
21.03.20174.74
14.03.20174.57
07.03.20174.68
28.02.20174.66
21.02.20174.62
14.02.20174.50
07.02.20174.60
31.01.20174.60
24.01.20174.43
17.01.20174.42
10.01.20174.49
03.01.20174.17
27.12.20163.65
19.12.20164.04
12.12.20163.93
05.12.20164.16
28.11.20164.22
21.11.20164.37
14.11.20164.12
07.11.20163.45
31.10.20163.71
24.10.20164.27
17.10.20164.34
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
4.44n/a
Market Capitalisation
in million USD
69n/a
Enterprise Value
in million USD
56n/a
Common Shares Outstanding
as per Jun 30, 2016
15,444,843n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
15,448,000n/a
Average Diluted Shares Outstanding
TTM
15,838,000n/a
Index Membership
n/a
Business Summary
Sharps Compliance Corp is a provider of waste management services including medical, pharmaceutical and hazardous. It serve customers in multiple markets such as home health care, retail clinics and pharmaceutical manufacturers.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 33n/a
Gross Profit 11n/a
Operating Income 0n/a
EBITDA 1n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 12n/a
Receivables 6n/a
Total Current Assets 23n/a
PP&E 5n/a
Total Assets 30n/a
Accounts Payable 2n/a
Current Debt 0n/a
Total Current Liabilities 6n/a
Long-Term Debt 0n/a
Total Liabilities 6n/a
Total Equity 24n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital 0n/a
Operating Cash Flow 1n/a
Net Change in PP&E and Intangibles -2n/a
Investing Cash Flow -3n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash -3n/a
Free Cash Flow -1n/a
Profitability Ratios
Gross Margin 33.3%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.1%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS 0.00n/a
Diluted EPS 0.00n/a
Sales per Share 2.16n/a
Book Value per Share 1.54n/a
FCF per Share -0.09n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 5,276.09n/a
Price to Sales Ratio 2.05n/a
Price to Book Value 2.88n/a
Price to Free Cash Flow -46.88n/a
Valuation Metrics
EV/EBITDA 68.38n/a
EV/Sales 1.68n/a
Book to Market Value 0.35n/a
Other Ratios
Current Ratio 406.0%n/a
Liabilities to Equity Ratio 26.4%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 84% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
39
19
22
22
27
31
33
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-16
-13
-15
-15
-18
-20
-22
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
24
6
7
6
9
11
11
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-9
-10
-9
-9
-10
-10
-11
Selling, General & Administrative
-9
-10
-9
-9
-9
-9
-11
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
14
-4
-3
-3
-1
1
0
Non-Operating Income (Loss)
0
0
0
0
0
0
0
Interest Expense, net
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
14
-4
-2
-3
-1
1
0
Abnormal Gains (Losses)
0
-1
0
0
2
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
14
-4
-2
-3
1
1
0
Income Tax (Expense) Benefit, net
-5
2
-1
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
9
-3
-4
-3
1
1
0
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
9
-3
-4
-3
1
1
0
Minority Interest
0
0
0
0
0
0
0
Net Income
9
-3
-4
-3
1
1
0
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
9
-3
-4
-3
1
1
0
Remarks
restated on Aug 30, 2012 n/a
calculated values,
restated on Aug 29, 2013 n/a
calculated values,
restated on Aug 27, 2014 n/a
calculated values,
restated on Aug 26, 2015 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
18
17
16
14
15
12
Cash & Cash Equivalents
n/a
18
17
16
14
15
12
Short Term Investments
n/a
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
3
2
3
5
7
6
Accounts Receivable, Net
n/a
3
2
3
5
7
6
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
2
2
2
1
3
4
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
1
1
1
2
1
1
Prepaid Expenses
n/a
1
1
1
0
1
1
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
2
0
0
Total Current Assets
n/a
24
23
20
22
25
23
Property, Plant & Equipment, Net
n/a
5
5
4
4
4
5
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
1
0
1
1
1
2
Intangible Assets
n/a
0
0
1
1
1
1
Goodwill
n/a
0
0
0
0
0
1
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
1
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
0
Total Noncurrent Assets
n/a
6
5
5
5
5
7
Total Assets
n/a
31
28
26
26
30
30
Liabilities and owners' equity
Payables & Accruals
n/a
2 2225000
2 2054000
2 2430000
3 2663000
4 3722000
3 3154000
Accounts Payable
n/a
1 965000
1 752000
1 1085000
2 1617000
2 1770000
2 1620000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
1 1260000
1 1302000
1 1345000
1 1046000
2 1952000
2 1534000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
2 1724000
2 1881000
1 1351000
1 1337000
2 1877000
2 2477000
Deferred Revenue
n/a
2 1724000
2 1881000
1 1351000
1 1337000
2 1877000
2 2477000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
4 3949000
4 3935000
4 3781000
4 4000000
6 5599000
6 5631000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
1 784000
1 523000
1 681000
1 557000
1 566000
1 673000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 401000
0 358000
1 579000
1 524000
0 483000
0 483000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 383000
0 165000
0 102000
0 33000
0 83000
0 190000
Total Noncurrent Liabilities
n/a
1 784000
1 523000
1 681000
1 557000
1 566000
1 673000
Total Liabilities
n/a
5 4733000
4 4458000
4 4462000
5 4557000
6 6165000
6 6304000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
22 21753000
23 22689000
23 23365000
24 23850000
25 24500000
25 25489000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 -74000
-1 -681000
-1 -809000
-2 -1554000
Retained Earnings
n/a
4 4112000
0 491000
-2 -2221000
-1 -1265000
0 -105000
0 -92000
Other Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Equity Before Minority Interest
n/a
26 25865000
23 23180000
21 21070000
22 21904000
24 23586000
24 23843000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
26 25865000
23 23180000
21 21070000
22 21904000
24 23586000
24 23843000
Total Liabilities & Equity
n/a
31 30598000
28 27638000
26 25532000
26 26461000
30 29751000
30 30147000
Remarks restated on n/a restated on Aug 30, 2012 n/a restated on Aug 29, 2013 n/a restated on Aug 27, 2014 n/a restated on Aug 26, 2015 n/a restated on Aug 25, 2016 n/a restated on Aug 25, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
9
-3
-4
-3
1
1
0
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
1
1
1
1
1
1
1
Non-Cash Items
1
0
2
0
1
1
1
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-2
2
0
0
-3
0
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
9
0
0
-1
-1
2
1
Change in Fixed Assets & Intangibles
-3
-1
-1
-1
-1
-1
-2
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
-2
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-3
-1
-1
-1
-1
-1
-3
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
6
0
0
0
-1
0
0
Increase in Capital Stock
6
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
-1
0
-1
Other Financing Activities
1
1
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
7
1
0
0
-1
0
0
Net Cash Before Disc. Operations and FX
13
0
-1
-2
-2
1
-3
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
13
0
-1
-2
-2
1
-3
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
13
0
-1
-2
-2
1
-3
Remarks
restated on Aug 30, 2012 n/a
calculated values,
restated on Aug 29, 2013 n/a
calculated values,
restated on Aug 27, 2014 n/a
calculated values,
restated on Aug 26, 2015 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo